ophthalmic indications

Related by string. * Ophthalmic . ophthalmics . Ophthalmics : contact lenses ophthalmic . cyclosporine ophthalmic emulsion . niche ophthalmic . sterile ophthalmic otic . erythromycin ophthalmic ointment / Indications . Indication . INDICATIONS . INDICATION : oncology indications . indications intermediates . contra indications . clearest indication yet . Initial indications * *

Related by context. Frequent words. (Click for all words.) 66 oncology indications 65 ophthalmic diseases 62 humanized monoclonal antibody 62 injectable formulation 61 ocular diseases 60 clofarabine 60 Chrysalin 59 ocular hypertension 59 nitric oxide donating 59 AzaSite 59 TREANDA 59 investigational compounds 59 Icatibant 59 Nimotuzumab 58 autoimmune indications 58 Zelrix 58 voclosporin 58 antisense drug 58 VEGF Trap 58 retinal disorders 58 IND enabling 57 ocrelizumab 57 AZX# 57 diabetic macular edema DME 57 topical formulation 57 Cethrin 57 Homspera 57 ecallantide 57 therapeutic monoclonal antibodies 56 hematological cancers 56 6R BH4 56 talactoferrin 56 Relistor 56 PREOS 56 hematological malignancies 56 diabetic macular edema 56 ciclesonide 55 RNAi therapeutic 55 NGX# 55 blepharitis 55 crofelemer 55 rNAPc2 55 DB# [003] 55 regadenoson 55 BiTE antibody 55 diabetic neuropathic pain 55 Phase 2b clinical 55 BAY #-# 55 investigational 55 Phase III clinical 55 refractory Hodgkin lymphoma 55 confirmatory Phase III 55 Leukine 55 Kyowa Hakko Kirin 55 Nexavar ® 55 anti infective 55 Amigal 55 Synavive 54 investigational drug 54 Phenoptin 54 Loramyc ® 54 tamibarotene 54 MOZOBIL 54 anticancer agent 54 allergic conjunctivitis 54 methylnaltrexone 54 DR Cysteamine 54 microplasmin 54 RGB # 54 Phase III clinical trials 54 MOR# 54 hematologic malignancies 54 MBP# [001] 54 Serdaxin 54 organ transplant rejection 54 MAXY G# 54 Allovectin 7 R 54 retigabine 54 immunotherapeutic 54 diabetic nephropathy 54 preclinical compounds 54 PS# [001] 54 therapeutics 54 photodynamic therapy PDT 54 Ventavis 53 antibody therapies 53 Phase Ib 53 tezampanel 53 oncology therapeutics 53 DAVANAT R 53 immune mediated 53 orphan designation 53 eculizumab 53 Tygacil 53 maribavir 53 seborrheic dermatitis 53 bacterial conjunctivitis 53 MGCD# [001] 53 Ceragenix 53 CNS disorders 53 FOLOTYN

Back to home page